Join
Live feed
·
PRReleasevia Quantisnow
Cocrystal Pharma Inc. logo

Cocrystal Pharma Reports Second Quarter 2023 Financial Results and Provides Updates on its Antiviral Drug Development Programs

ByQuantisnow·Wall Street's wire, on your screen.
COCP· Cocrystal Pharma Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track COCP (Cocrystal Pharma Inc.) and more on Quantisnow.